Risk marker profiles in patients treated with percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy

被引:0
|
作者
Amelie Burghardt
Frank van Buuren
Zisis Dimitriadis
Tim Grübbel
Hubert Seggewiss
Smita Scholtz
Dieter Horstkotte
Lothar Faber
机构
[1] Ruhr-Universität Bochum,Clinic for Cardiology, Herz
[2] Leopoldina Hospital, und Diabeteszentrum NRW
来源
关键词
Hypertrophic obstructive cardiomyopathy; HOCM; ICD; Left ventricular outflow tract gradient; Percutaneous septal ablation; Sudden cardiac death;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:479 / 486
页数:7
相关论文
共 50 条
  • [21] Prediction of the risk of pacemaker dependency after percutaneous septal ablation for hypertrophic obstructive cardiomyopathy
    Faber, L
    Seggewiss, H
    Werlemann, BC
    Fassbender, D
    Schmidt, HK
    Horstkotte, D
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 173A - 173A
  • [22] Therapeutic effects of alcohol septal ablation in mildly symptomatic patients with hypertrophic obstructive cardiomyopathy
    李佩瑾
    ChinaMedicalAbstracts(InternalMedicine), 2022, 39 (02) : 95 - 96
  • [23] Septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: An analysis of the patients with dissatisfactory intervention results
    Faber, L
    Welge, D
    Ziemssen, P
    Seggewiss, H
    Fassbender, D
    Horstkotte, D
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 145A - 145A
  • [24] Left ventricular remodeling in patients with hypertrophic obstructive cardiomyopathy treated with percutaneous alcohol septal ablation:: an echocardiographic study
    Rivera, S
    Sitges, M
    Azqueta, M
    Marigliano, A
    Velamazcán, M
    Miranda-Guardiola, F
    Betriu, A
    Paré, C
    REVISTA ESPANOLA DE CARDIOLOGIA, 2003, 56 (12): : 1174 - 1181
  • [25] Percutaneous septal ablation after unsuccessful surgical myectomy for patients with hypertrophic obstructive cardiomyopathy
    Lothar Faber
    Dirk Welge
    Detlef Hering
    Thomas Butz
    Olaf Oldenburg
    Hubert Seggewiss
    Dieter Horstkotte
    Clinical Research in Cardiology, 2008, 97 : 899 - 904
  • [26] Percutaneous septal ablation in patients with hypertrophic obstructive cardiomyopathy results in improvement of exercise capacity
    Ziemssen, P
    Faber, L
    Schlichting, J
    Meyners, W
    Horstkotte, D
    Seggewiss, H
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) : 182A - 182A
  • [27] Percutaneous septal ablation after unsuccessful surgical myectomy for patients with hypertrophic obstructive cardiomyopathy
    Faber, Lothar
    Welge, Dirk
    Hering, Detlef
    Butz, Thomas
    Oldenburg, Olaf
    Seggewiss, Hubert
    Horstkotte, Dieter
    CLINICAL RESEARCH IN CARDIOLOGY, 2008, 97 (12) : 899 - 904
  • [28] Transluminal percutaneous septal myocardial ablation in a patient with hypertrophic obstructive cardiomyopathy
    Tsuchikane, E
    Nakamura, T
    Yamazaki, K
    Kitano, K
    Izumi, M
    Otsuji, S
    Tateyama, H
    Awata, N
    Sakurai, M
    Kobayashi, T
    JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1998, 62 (07): : 537 - 540
  • [29] Percutaneous septal ablation with absorbable gelatin sponge in hypertrophic obstructive cardiomyopathy
    Llamas-Esperon, Guillermo A.
    Sandoval-Navarrete, Santiago
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2007, 69 (02) : 231 - 235
  • [30] APPLICATION OF PERCUTANEOUS TRANSLUMINAL SEPTAL MYOCARDIAL ABLATION ON HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
    Wang Yu
    Liu Hongming
    Zhang Hongjie
    Guo Tao
    HEART, 2012, 98 : E250 - E250